Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baloxavir marboxil vs oseltamivir in otherwise healthy pediatric patients with influenza-like symptoms
2018-002169-21Phase 3Completed
- Sponsor
- Roche
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of baloxavir marboxil in influenza (2 arms), sponsored by Roche. Primary endpoint: Safety endpoints. Started Sep 2018; status: completed.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on 2018-002169-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002169-21.